Abstract
ObjectiveThere has been limited systematic evaluation of outcomes and drivers of inappropriate non-vitamin K antagonist oral anticoagulants (NOACs) dosing among patients with atrial fibrillation (AF). This review identified and systematically...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have